NVLN - Novelion Therapeutics Inc.
Previous close
0.68
0.680 100.000%
Share volume: 0
Last Updated: Tue 08 Oct 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
44%
Profitability
51%
Dept financing
40%
Liquidity
5%
Performance
48%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.15%
Return on assets
-4.54%
Return on sales
-60.14%
Return on invested capital
19.91%
Total debt ratio
92.64%
Debt ratio change over timeo
-3.75%
Current Ratio
2.6%
Quick Ratio
0.94%
Cash Position Ratio
0.59%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
38.51%
Return on assets
-3.14%
Return on sales
-33.69%
Return on invested capital
7.34%
Total debt ratio
123.82%
Debt ratio change over timeo
0.01%
Current Ratio
0.51%
Quick Ratio
0.43%
Cash Position Ratio
0.28%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
26.77%
Return on assets
-4.67%
Return on sales
-49.65%
Return on invested capital
15.34%
Total debt ratio
134.77%
Debt ratio change over time
10.88%
Current Ratio
0.24%
Quick Ratio
0.21%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.64%
Return on assets
-78.91%
Return on sales
178.87%
Return on invested capital
-19.45%
Total debt ratio
-375.42%
Debt ratio change over time
-3.75%
Current Ratio
-6.96%
Quick Ratio
-6.07%
Cash Position Ratio
-3.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NVLN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | 3.15% | 1.07% | -8.14% | -11.28% |
| Return on assets | -4.54% | -21.62% | -6.71% | -9.53% |
| Return on sales | -60.14% | -5539.23% | 0% | -329.56% |
| Return on invested capital | 19.91% | 301.48% | -259.37% | -130.53% |
| Profitability | 52% | 33% | 25% | 0% |
| Total debt ratio | 92.64% | 142.14% | 23.84% | 22.13% |
| Debt ratio change over time | -3.75% | 0.23% | -0.97% | -1.29% |
| Dept financing | 16% | 50% | 4% | 4% |
| Current Ratio | 0.51% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0.43% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.28% | 12.6% | 2.56% | 2.63% |
| Liquididy | 11% | 44% | 24% | 60% |
| Short-term ratios | NVLN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | 38.51% | -33.15% | -14.36% | -5.02% |
| Return on assets | -3.14% | -15.13% | -9.55% | -6.38% |
| Return on sales | -33.69% | -13599.98% | 0% | -333.95% |
| Return on invested capital | 7.34% | 571.73% | -381.13% | 16.96% |
| Profitability | 50% | 25% | 25% | 1% |
| Total debt ratio | 123.82% | 48.84% | 23.99% | 33.94% |
| Debt ratio change over time | 0.01% | -0.68% | -1.37% | -1.49% |
| Dept financing | 50% | 10% | 5% | 7% |
| Current Ratio | 0.51% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0.43% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.28% | 12.6% | 2.56% | 2.63% |
| Liquididy | 3% | 50% | 18% | 51% |